Inventor

Yuiko Sahara

Inventor
Yokohama, JP

Overview

22→
Patents
2010–2018
Patent span
Chemistry
Primary field (CPC C)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes22%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
C07KPeptides17%
C07DHeterocyclic compounds10%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
C12YEnzymes2%
PatentTitleYear
10,156,557Calcium-binding photoprotein20189,738,692'Process for production of recombinant proteins as a soluble form'20179,645,128'Substituted imidazo[1,2-A]pyrazines for measuring a transcription activity'20179,151,739'Coelenterazine analogs and manufacturing method thereof'20159,075,058'Coelenterazine analogues and coelenteramide analogues'20159,056,840'Coelenterazine analogues and coelenteramide analogues'20158,883,432'Coelenterazine analogues and coelenteramide analogues'20148,853,374'Process for production of recombinant proteins as a soluble form'20148,772,452'Calcium-binding photoprotein'20148,765,921'Coelenterazine analogs and manufacturing method thereof'20148,642,281'Coelenterazine analogues and coelenteramide analogues'20148,569,003'Fusion protein having luminescence activity'20138,563,270'Calcium-binding photoprotein, gene encoding the same, and use thereof'20138,546,568'Coelenterazine analogs and manufacturing method thereof'20138,481,702'Fusion protein having luminescence activity'20138,476,038'Method for determining capability of a compound for inhibiting a receptor using codon-optimized nucleic acid'20138,476,436'Method for enhancing luminescence intensity of clytin-II'20138,399,616'Fusion protein having luminescence activity'20138,394,603'Codon-optimized nucleic acid for coding apo-clytin-II and method for using the same'20138,236,526'Calcium-binding photoprotein, gene encoding the same, and use thereof'20127,888,087'Fusion protein of Fc-binding domain and calcium-binding photoprotein, gene encoding the same and use thereof'20117,666,980'Calcium-binding photoprotein, gene encoding the same, and use thereof'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2017Based in Yokohama, JP· patent location history
2012–2018Patents assigned to JNC CORP (20)· patent assignee history
2012–2014Patents assigned to INOUYE SATOSHI (10)· patent assignee history
2012–2014Patents assigned to SAHARA YUIKO (10)· patent assignee history
2013Patents assigned to SATO JUNICHI (4)· patent assignee history
2013–2018Based in Kanagawa, JP· patent location history
2013Based in Tokyo, JP· patent location history
2014–2015Patents assigned to NAT UNIV CORP TOKYO MED & DENT (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JNC CORP202012–2018
INOUYE SATOSHI102012–2014
SAHARA YUIKOself102012–2014
NAT UNIV CORP TOKYO MED & DENT42014–2015
SATO JUNICHI42013
Locations
LocationPatentsSpan
Yokohama, JP142010–2017
Kanagawa, JP72013–2018
Tokyo, JP12013